Brain tumor inflammation study using a new imaging agent
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new PET scan tracer to see inflammation in brain tumors that have not been treated with radiation. It may help doctors better understand and monitor these tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a brain tumor (either primary or spread from another cancer) that has not been treated with radiation.
- You are not pregnant or breastfeeding.
- You do not have severe claustrophobia or conditions that would make lying still for a PET/CT/MRI scan unsafe.
- You have not had radiation to the brain before.
- You are not allergic to the study tracer or its components.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether a specialized PET scan tracer can “light up” metastatic non-small cell lung cancer in the brain. If you join, you’ll get brain MRI and PET/CT scans and you’ll continue with your planned cancer treatments and follow-up imaging.
This trial uses a special PET scan tracer called 18F-FMISO to see areas of low oxygen (hypoxia) in your tumor. The results may help doctors adjust your radiation plan to target those areas more precisely.
This study uses a special type of brain scan (PET imaging) to better understand how cancer that has spread to the brain responds to radiation treatment. The scan may help doctors see which patients are responding well to treatment.
This study uses a special PET scan to look for inflammation in the brains of people with Alzheimer's or related dementias. It may help researchers understand how inflammation affects memory and thinking problems.
This study uses brain scans to look for hidden inflammation in people with multiple sclerosis who have not yet started a strong treatment. It aims to understand how this inflammation affects the disease and to help guide future therapies.
This trial uses a special MRI scan that shows how “metabolism” (how cells use fuel) differs in brain tumors. It may help researchers better understand tumor biology and how tumors may respond to treatment, without using chemotherapy or radiation as part of the study.
Hear when a new Central Nervous System Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.